title: Sandoz sues FDA over delay in first biogeneric approval.
authors.forename: Jeffrey L
authors.initials: JL
authors.lastname: Fox
mesh_terms: D001709:Biotechnology / Q000331:legislation & jurisprudence*; D017277:Drug Approval; D004345:Drug Industry / Q000331:legislation & jurisprudence* / Q000639:trends*; D016568:Drugs, Generic / Q000592:standards*; D019382:Human Growth Hormone / Q000627:therapeutic use; D007880:Legislation, Drug; D011994:Recombinant Proteins / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016568:Drugs, Generic; D011994:Recombinant Proteins; D019382:Human Growth Hormone